Protea Biosciences, Inc. is a Proteomics company, based in Morgantown, West Virginia, that has been founded to advance and commercialize new Proteomics technology, and provide innovative services and products, for use by proteomics research laboratories.The Founders of the company include Stephen Turner, founder of several successful biotechnology companies, and a team of leading researchers at the West Virginia University Health Sciences Center Protea’s Scientific Advisors are as follows:
| John Barnett, PhD |
Professor and Chairman of the Department of Microbiology, Immunology and Cell Biology,
WVU. Dr. Barnett has an extensive background in the fields of immunology and immune responsiveness (signal transduction cascades). |
| Barbara Ducatman, M.D. |
Professor and Chairman of the Department of Pathology, WVU School of Medicine. |
| Daniel Flynn, PhD. |
Associate Professor of Microbiology, Immunology and Cell Biology, and Associate Director for Basic Research, the Mary Babb Randolph Cancer Center,
WVUHSC. Dr. Flynn is responsible for the cell signaling research program. |
| Aaron Timperman, PhD. |
Assistant Professor of Chemisty. Dr. Timperman came to WVU from the University of Washington Department of Molecular Biotechnology, andspecializes in the development and application of microfluidics technology to
Proteomics. |
| William Wardell, M.D., Ph.D. |
Formerly Senior Vice President, Drug Development, Parke-Davis,and a Merck International Fellow in Clinical Pharmacology.
|
